IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Go back to IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
(NASDAQ: IGMS) Delayed: 1.27 --0 (-0%)
Previous Close $1.27    52 Week High
Open $1.27    52 Week Low
Day High $1.27    P/E N/A 
Day Low $1.27    EPS
Volume 2,475,329